Search Results - "Taskinen, M.R."

Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans.

Authors: Packard, C.J. Taskinen, M.R. Björnson, E. et al.

Source: Atherosclerosis (00219150). May2025, Vol. 404, pN.PAG-N.PAG. 1p.

Prevalence and 2010-15 secular trends in sugar-sweetened beverages sales in Europe and the Middle East.

Authors: Arsenault, B. Taskinen, M.R. Després, J.P.

Source: Atherosclerosis (00219150). Sep2016, Vol. 252, pe210-e211. 1p.

Effect of acute vigorous exercise on lipoprotein lipase activity of adipose tissue and skeletal muscle in physically active men.

Authors: Taskinen, M.R. Nikkila, E.A.

Source: Artery. 1980: Vol. 6 Issue 6. p. 471-483-483.

Seerumin pieni HDL-kolesterolipitoisuus nuorella kehonrakentajalla.

Authors: Kahri, J. Ilmonen, M. Taskinen, M.R.

Source: Duodecim. 1992: Vol. 108 Issue 9. p. 889-892-892.

Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins.

Authors: Nikkila, E.A. Taskinen, M.R. Rehunen, S. et al.

Source: Metabolism: Clinical & Experimental. Nov, 1978: Vol. 27 Issue 11. p. 1661-1667-1667.

Hepatic Saturated Fatty Acid Fraction Is Associated With De Novo Lipogenesis And Hepatic Insulin Sensitivity In Overweight And Obese Subjects.

Authors: Roumans, K. Veeraiah, P. Phielix, E. et al.

Source: Atherosclerosis (00219150). Aug2019, Vol. 287, pe95-e95. 1p.

Polygenic Hyperlipidemia Increases Coronary Artery Disease Risk In The Uk Biobank.

Authors: Ripatti, P. Rämö, J.T. Söderlund, S. et al.

Source: Atherosclerosis (00219150). Aug2019, Vol. 287, pe92-e92. 1p.

Adipocyte Size In Obesity With And Without Metabolic Syndrome.

Authors: Koskimies, J. Heinonen, S. Jukarainen, S. et al.

Source: Atherosclerosis (00219150). Aug2019, Vol. 287, pe72-e72. 1p.

We-P11:62 Reduction of large VLDL particles by fenofibrate is associated with reduction of small dense LDL in type 2 diabetes: Field Helsinki substudy

Authors: Hiukka, A. Leinonen, E. Hilden, H. et al.

Source: Atherosclerosis (Supplements). Jun2006, Vol. 7 Issue 3, p359-360. 2p.

Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in four phase 3 odyssey trials with/without statin background.

Authors: Robinson, J.G. Farnier, M. Kastelein, J.J. et al.

Source: Atherosclerosis (00219150). Sep2016, Vol. 252, pe231-e231. 1p.

A ubiquitous transcription factor influences diet-induced thermogenesis and sensitizes BAT to noradrenergic stimuli improving cardiometabolic health.

Authors: Laurila, P.P. Soronen, J. Kooijman, S. et al.

Source: Atherosclerosis (00219150). Sep2016, Vol. 252, pe244-e244. 1p.

Investigation of multiple dyslipidemias in a large Austrian pedigree by genetic risk scores and exome sequencing.

Authors: Nikkola, E. Ko, A. Cantor, R.M. et al.

Source: Atherosclerosis (00219150). Sep2016, Vol. 252, pe253-e253. 1p.

We-P11:234 Hepatic nuclear factor 4 alpha gene implicated in finnish and Mexican familial combined hyperlipidemia families

Authors: Huertas-Vazquez, A. Weissglas, D. Tusie, T. et al.

Source: Atherosclerosis (Supplements). Jun2006, Vol. 7 Issue 3, p397-397. 1p.

We-W44:5 A two step strategy to localize gene(s) influencing low high-density lipoprotein cholesterol level on chromosome 16Q23-24

Authors: Lee, J.L. Aouizerat, B. Genest, J. et al.

Source: Atherosclerosis (Supplements). Jun2006, Vol. 7 Issue 3, p333-333. 1p.

W12.303 Liver fat is a determinant of postprandial lipemia

Authors: Mänttäri, S. Soro-Paavonen, A. Häkkinen, A.M. et al.

Source: Atherosclerosis (Supplements). Apr2004, Vol. 5 Issue 1, p70-70. 1p.

W01.124 Chromosome 10Q11 associated with HDL-C levels in finnish dyslipidemic families

Authors: Lilja, H. Suviolahti, E. Perola, M. et al.

Source: Atherosclerosis (Supplements). Apr2004, Vol. 5 Issue 1, p28-28. 1p.